With the Spike & Go, pharmacists can now provide the first chemotherapy product that comes in a premixed, ready-to-infuse formulation called INFUGEM™ by Sun Pharma. This alcohol-free, clear, colorless, sterile solution of 10mg/mL gemcitabine in 0.9% sodium chloride involves dose banding practice, whereby standardized doses of intravenous cytotoxic drugs are used for ranges (or “bands”) of doses calculated for individual patients.
The patients who receive this prepared bag in combination with other drugs are treating their breast, ovarian, non-small cell lung cancers, and as a single agent for the treatment of pancreatic cancer.
INFUGEM improves provider and patient experiences by using high-tech delivery systems for novel medicines. The package minimizes the risk of manual compounding and drug contamination and reduces the complexity of infusion.
The Spike & Go with INFUGEM is the first product using Sun’s proprietary technology that allows cytotoxic oncology products to be premixed in a sterile environment and supplied to the prescribers in ready-to-infuse final dosage bags.
This post is related to:Pharmaceutical Manufacturers